Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2017-06-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Balance Training With tDCS for CAI
NCT04390048
Telemonitored Exercise to Attenuate Metabolic Dysregulation in Spinal Cord Injury
NCT05597176
Training of Eccentric Lower Extremity Function After SCI
NCT02498548
A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients
NCT06494059
Cerebellar tDCS and Balance Training in PwMS
NCT04391023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NMES + MMBI
Neuromuscular electrical stimulation applied to hip abductors along with participation in a multi-modality balance intervention
Neuromuscular electrical stimulation (NMES)
Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 24 weeks
Multi-Modality Balance Intervention (MMBI)
Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 24 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuromuscular electrical stimulation (NMES)
Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 24 weeks
Multi-Modality Balance Intervention (MMBI)
Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 24 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
2. COPD requiring home oxygen
3. Contraindications to resistance training, including a self-reported history of intracranial or retinal bleeding in the last year or Diabetes with active proliferative retinopathy
4. Patient report of significant spinal stenosis that would limit participation in the exercise intervention
5. Non-ambulatory mobility status or a transtibial or transfemoral amputation
6. Dementia (on medical record review or mini-mental status exam score \<24).
7. Other severe medical illness or condition that would preclude safe participation in the study as determined by the study team
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baltimore VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Odessa Addison
Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Les Katzel, MD, PhD
Role: STUDY_DIRECTOR
Director Baltmore GRECC
Odessa Addison, DPT, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baltimore VA Medical Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00072630
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.